Terminal Cancer Survival Rates & Laetrile/B17: What You Need to Know

Terminal cancer survival varies by type, stage, and treatment. Early-stage breast/prostate cancers have high survival rates; late-stage lung/pancreatic cancers have lower rates.

Laetrile (B17) has been promoted as alternative cancer therapy but lacks scientific evidence of efficacy. It can be harmful, causing nausea, vomiting, diarrhea. Rely on evidence-based treatments under medical supervision.